[{"Physician_Profile_ID": "841636", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "580.00", "Date_of_Payment": "11/01/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31509894", "Name_of_Associated_Covered_Drug_or_Biological1": "SYNCRIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "A Randomized, Open Label, Parallel Group, Multicenter Study to Determine the Efficacy and Long Term Safety of Albiglutide Compared With Insulin in Subjects With Type 2 Diabetes Mellitus", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "841636", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "150.00", "Date_of_Payment": "12/10/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31509897", "Name_of_Associated_Covered_Drug_or_Biological1": "SYNCRIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "A Randomized, Double blind, Placebo   and Active   Controlled, Parallel group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and with Metformin plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "841636", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "115.00", "Date_of_Payment": "12/04/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31509895", "Name_of_Associated_Covered_Drug_or_Biological1": "SYNCRIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "A Randomized, Double Blind, Placebo  and Active Controlled, Parallel Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "841636", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "115.00", "Date_of_Payment": "12/04/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31509896", "Name_of_Associated_Covered_Drug_or_Biological1": "SYNCRIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "A Randomized, Double Blind, Placebo  and Active Controlled, Parallel Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus", "Research_Information_Link": "", "Context_of_Research": ""}]